Rapport Therapeutics (RAPP) Stock Chart & Stock Price History $12.10 -1.06 (-8.05%) Closing price 06/11/2025 04:00 PM EasternExtended Trading$12.10 0.00 (0.00%) As of 03:59 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Rapport Therapeutics Stock Price Performance The Rapport Therapeutics (RAPP) stock chart highlights key performance trends across multiple timeframes. Since the beginning of the year, the stock decreased 31.79%. In the past month, the stock has increased 15.57%, reflecting recent market activity. As of the latest close, Rapport Therapeutics traded at $12.10 with a market cap of $441.63 million and volume of 101,219 shares. Receive RAPP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Rapport Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-4.42%1 Month Performance+15.57%3 Month Performance+20.88%Year-To-Date Performance-31.79% RAPP Stock Chart for Thursday, June, 12, 2025 RAPP Chart by TradingView Rapport Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/11/2025$13.16$12.10-8.05%$13.39$11.87101,219 shs$441.63 million06/10/2025$12.71$13.16+3.54%$13.77$12.33155,930 shs$480.31 million06/09/2025$12.66$12.71+0.39%$14.43$12.0888,800 shs$463.89 million06/06/2025$12.33$12.66+2.68%$13.13$12.19196,294 shs$462.07 million06/05/2025$13.06$12.33-5.59%$14.48$12.31180,520 shs$450.02 million06/04/2025$12.24$13.06+6.70%$14.78$12.11430,411 shs$476.66 million06/03/2025$9.40$12.24+30.21%$12.74$9.17689,607 shs$446.74 million06/02/2025$8.40$9.40+11.90%$9.63$8.20577,442 shs$343.08 million05/30/2025$8.51$8.40-1.29%$8.79$7.73417,110 shs$306.58 million05/29/2025$9.51$8.51-10.52%$9.08$8.13189,153 shs$310.60 million Get the Latest News and Ratings for RAPP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Rapport Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/28/2025$10.04$9.51-5.28%$10.15$9.33138,054 shs$347.10 million05/27/2025$10.82$10.04-7.21%$11.28$9.91112,510 shs$366.44 million05/26/2025$10.82$10.82$11.82$10.75206,082 shs$394.91 million05/23/2025$11.12$10.82-2.70%$11.82$10.75206,082 shs$394.91 million05/22/2025$10.04$11.12+10.76%$11.31$9.60245,028 shs$405.86 million05/21/2025$10.22$10.04-1.76%$11.20$9.98176,170 shs$366.44 million05/20/2025$10.19$10.22+0.29%$10.39$9.90246,483 shs$373.01 million05/19/2025$9.96$10.19+2.31%$10.29$9.58151,674 shs$371.92 million05/16/2025$9.76$9.96+2.05%$10.29$9.76163,466 shs$363.52 million05/15/2025$9.63$9.76+1.35%$9.81$9.20105,524 shs$356.22 million05/14/2025$9.99$9.63-3.60%$10.08$9.40134,652 shs$351.48 million05/13/2025$10.47$9.99-4.58%$10.79$9.86105,358 shs$364.62 million05/12/2025$10.25$10.47+2.15%$10.83$10.1099,644 shs$382.13 million Related Companies INDV Stock Chart GLPG Stock Chart APGE Stock Chart BEAM Stock Chart IMCR Stock Chart TARS Stock Chart BHC Stock Chart IRON Stock Chart BHVN Stock Chart ARQT Stock Chart Receive RAPP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Rapport Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:RAPP) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredMarch 16th -- America’s most important day?50-Year Legend: Here's The Day Stocks Likely Crash Legendary quant analyst Marc Chaikin says in 50 years on...Chaikin Analytics | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rapport Therapeutics Please log in to your account or sign up in order to add this asset to your watchlist. Share Rapport Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RAPP Stock Free RAPP Stock Alerts